EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Overcoming the effects of fluid shear stress in ovarian cancer cell lines: Doxorubicin alone or photodynamic priming to target platinum resistance

Marta Overchuk iD, Brittany P Rickard iD, Justin Tulino, Xianming Tan iD, Frances S Ligler iD, Huang-Chiao Huang iD, Imran Rizvi iD

Photochemistry and Photobiology · 2024

DOI: 10.1111/php.13967 ↗

At a glance

Journal article in Photochemistry and Photobiology, 2024. Written by Marta Overchuk and 6 co-authors. Institution: Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carol…. Major MEDLINE topics: Doxorubicin, Ovarian Neoplasms, Drug Resistance, Neoplasm, Photochemotherapy. Cited 5 times so far (Crossref); 111 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIEHS NIH HHS, NIH HHS, NCI NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Resistance to platinum‐based chemotherapies remains a significant challenge in advanced‐stage high‐grade serous ovarian carcinoma, and patients with malignant ascites face the poorest outcomes. It is, therefore, important to understand the effects of ascites, including the associated fluid shear stress (FSS), on phenotypic changes and therapy response, specifically FSS‐induced chemotherapy resistance and the underlying mechanisms in ovarian cancer. This study investigated the effects of FSS on response to cisplatin, a platinum‐based chemotherapy, and doxorubicin, an anthracycline, both of which are commonly used to manage advanced‐stage ovarian cancer. Consistent with prior research, OVCAR‐3 and Caov‐3 cells cultivated under FSS demonstrated significant resistance to cisplatin. Examination of the role of mitochondria revealed an increase in mitochondrial DNA copy number and intracellular ATP content in cultures grown under FSS, suggesting that changes in mitochondria number and metabolic activity may contribute to platinum resistance. Interestingly, no resistance to doxorubicin was observed under FSS, the first such observation of a lack of resistance under these conditions. Finally, this study demonstrated the potential of photodynamic priming using benzoporphyrin derivative, a clinically approved photosensitizer that localizes in part to mitochondria and endoplasmic reticula, to enhance the efficacy of cisplatin, but not doxorubicin, thereby overcoming FSS‐induced platinum resistance.

Subjects

MeSH terms (MEDLINE)

DoxorubicinOvarian NeoplasmsDrug Resistance, NeoplasmPhotochemotherapyCisplatinFemaleHumansCell Line, TumorAntineoplastic AgentsStress, MechanicalMitochondriaPhotosensitizing Agents

Author keywords

benzoporphyrin derivativecisplatindoxorubicinhigh‐grade serous ovarian carcinomaovarian cancerphotodynamic priming

Substances

DoxorubicinCisplatinAntineoplastic AgentsPhotosensitizing Agents

Authors and institutions

  • Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
  • Curriculum in Toxicology & Environmental Medicine, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Biostatistics, University of North Carolina School of Public Health, Chapel Hill, North Carolina, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA.
  • Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.

ORCID profiles: Marta Overchuk, Brittany P Rickard, Xianming Tan, Frances S Ligler, Huang-Chiao Huang, Imran Rizvi

Funding

  • NIEHS NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Cite

APA

Overchuk, M., Rickard, B. P., Tulino, J., Tan, X., Ligler, F. S., Huang, H. C., & Rizvi, I. (2024). Overcoming the effects of fluid shear stress in ovarian cancer cell lines: Doxorubicin alone or photodynamic priming to target platinum resistance. Photochemistry and Photobiology. https://doi.org/10.1111/php.13967

Vancouver

Overchuk M, Rickard BP, Tulino J, Tan X, Ligler FS, Huang HC, et al. Overcoming the effects of fluid shear stress in ovarian cancer cell lines: Doxorubicin alone or photodynamic priming to target platinum resistance. Photochemistry and Photobiology. 2024. doi:10.1111/php.13967

BibTeX
@article{Overchuk2024,
  author = {Overchuk, Marta and Rickard, Brittany P and Tulino, Justin and Tan, Xianming and Ligler, Frances S and Huang, Huang-Chiao and Rizvi, Imran},
  title = {Overcoming the effects of fluid shear stress in ovarian cancer cell lines: Doxorubicin alone or photodynamic priming to target platinum resistance},
  journal = {Photochemistry and Photobiology},
  year = {2024},
  doi = {10.1111/php.13967}
}
Start for free →